Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response.
Yu Amanda GuoTanmay KulshresthaMei Mei ChangIrfahan KassamEgor RevkovSimone RizzettoAaron C TanDaniel Shao-Weng TanIain Beehuat TanAnders Jacobsen SkanderupPublished in: Cancer research communications (2024)
Our results challenge the prevailing dogma that cancer cells present tissue-agnostic molecular markers that modulate immune activity and ICB response, which has implications on the development of improved ICB diagnostics and treatments.